Expression and analysis of a split premature termination codon in FGG responsible for congenital afibrinogenemia: Escape from RNA surveillance mechanisms in transfected cells

Blood

Volumn 104, Issue 12, 2004, Pages 3618-3623

  Neerman Arbez, Marguerite ^a   Germanos Haddad, Myrna ^b   Tzanidakis, Konstantinos ^b   Vu, Dung ^b   Deutsch, Samuel ^b   David, Armelle ^b   Morris, Michael A ^b   De Moerloose, Philippe ^b  

^a UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; RNA;

AFIBRINOGENEMIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ETHNIC GROUP; EXON; FGA GENE; FGB GENE; FGG GENE; FIBRINOGEN DEFECT; GENE; GENE CLUSTER; GENE MUTATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; INTRON; LEBANON; NONHUMAN; NONSENSE MUTATION; NULL ALLELE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA ANALYSIS; RNA SPLICING; RNA STABILITY; STOP CODON;

EID: 9444229917     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2004-06-2312     Document Type: Article

References (29)

1. OMIM: online Mendelian Inheritance in Man. http://www.ncbi.nlm.nih.gov/ entrez/query.fcgi?db=OMIM. Accessed August 25, 2004.
2. Rabe F, Salomon E. Ueber-faserstoffmangel im Blute bei einem Falle von Hämophilie. Arch Int Med. 1920;95:2-14.
3. Lak M, Keihani M, Elahi F, Peyvandi F, Mannucci PM. Bleeding and thrombosis in 55 patients with inherited afibrinogenaemia. Br J Haematol. 1999; 107:204-206.
4. Al-Mondhiry H, Ehman WC. Congenital afibrinogenemia. Am J Hematol. 1994;46:343-347.
5. Neerman-Arbez M, Honsberger A, Antonarakis SE, Morris MA. Deletion of the fibrinogen alpha-chain gene (FGA) causes congenital afibrinogenemia. J Clin Invest. 1999;103:215-218.
6. Neerman-Arbez M. The molecular basis of inherited afibrinogenaemia. Thromb Haemost. 2001; 86:154-163.
7. Hanss M, Biot F. A database for human fibrinogen variants. Ann N Y Acad Sci. 2001;936:89-90. http://www.geht.org/databaseang/fibrinogen.
8. Maghzal GJ, Brennan SO, Homer VM, George PM. The molecular mechanisms of congenital hypofibrinogenaemia. Cell Mol Life Sci. 2004;61: 1427-1438.
9. Kant JA, Fornace Jr AJ, Saxe D, Simon MI, McBride OW, Crabtree GR. Evolution and organization of the fibrinogen locus on chromosome 4: gene duplication accompanied by transposition and inversion. Proc Natl Acad Sci U S A. 1985;82: 2344-2348.
10. Neerman-Arbez M, de Moerloose P, Bridel C, et al. Mutations in the fibrinogen A gene (FGA) account for the majority of cases of congenital afibrinogenemia. Blood. 2000;96:149-152.
11. Der Kaloustian V, Naffah J, Loiselet J. Genetic diseases in Lebanon. Am J Med Genet. 1980;7: 187-203.
12. Der Kaloustian V. Genetic diseases in Lebanon. Leb Med J. 1986;36:65-68.
13. Neerman-Arbez M, Vu D, Abu-Libdeh D, Bouchardy I, Morris MA. Prenatal diagnosis for congenital afibrinogenemia caused by a novel non-sense mutation in the FGB gene in a Palestinian family. Blood. 2003;101:3492-3494.
14. Antonarakis SE. Recommendations for a nomenclature system for human gene mutations. Nomenclature Working Group. Hum Mutat. 1998;11: 1-3.
15. Cartegni L, Chew SL, Krainer AR. Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat Rev Genet. 2002; 3:285-298.
16. Byers PH. Killing the messenger: new insights into nonsense-mediated mRNA decay. J Clin Invest. 2002;109:3-6.
17. Frischmeyer PA, Dietz HC. Nonsense-mediated mRNA decay in health and disease. Hum Mol Genet. 1999;8:1893-1900.
18. Hentze MW, Kulozik AE. A perfect message: RNA surveillance and nonsense-mediated decay. Cell. 1999;96:307-310.
19. Carter MS, Li S, Wilkinson MF. A splicing-dependent regulatory mechanism that detects translation signals. EMBO J. 1996;15:5965-5975.
20. Okumura N, Terasawa F, Tanaka H, et al. Analysis of fibrinogen gamma-chain truncations shows the C-terminus, particularly gammalle387, is essential for assembly and secretion of this multichain protein. Blood. 2002;99:3654-3660.
21. Duga S, Asselta R, Santagostino E, et al. Missense mutations in the human beta fibrinogen gene cause congenital afibrinogenemia by impairing fibrinogen secretion. Blood. 2000;95: 1336-1341.
22. Homer VM, Brennan SO, Ockelford P, George PM. Novel fibrinogen truncation with deletion of Bbeta chain residues 440-461 causes hypofibrinogenaemia. Thromb Haemost. 2002;88:427-431.
23. Vu D, Bolton-Maggs PHB, Parr J, Morris MA, de Moerloose P, Neerman-Arbez M. Congenital afibrinogenemia: identification and expression of a missense mutation in FGB impairing fibrinogen secretion. Blood. 2003;102:4413-4415.
24. Spena S, Asselta R, Duga S, et al. Congenital afibrinogenemia: intracellular retention of fibrinogen due to a novel W437G mutation in the fibrinogen Bbeta-chain gene. Biochim Biophys Acta. 2003;1639:87-94.
25. Asselta R, Duga S, Spena S, et al. Congenital afibrinogenemia: mutations leading to premature termination codons in fibrinogen A alpha-chain gene are not associated with the decay of the mutant mRNAs. Blood. 2001;98:3685-3692.
26. Dietz HC, Valle D, Francomano CA, Kendzior RJ Jr, Pyeritz RE, Cutting GR. The skipping of constitutive exons in vivo induced by nonsense mutations. Science. 1993;259:680-683.
27. Dietz HC, Kendzior RJ Jr. Maintenance of an open reading frame as an additional level of scrutiny during splice site selection. Nat Genet. 1994; 8:183-188.
28. Zhang J, Maquat LE. Evidence that translation reinitiation abrogates nonsense-mediated mRNA decay in mammalian cells. EMBO J. 1997;16: 826-833.
29. Romao L, Inacio A, Santos S, et al. Nonsense mutations in the human beta-globin gene lead to unexpected levels of cytoplasmic mRNA accumulation. Blood. 2000;96:2895-2901.